OCGN Q2 2021 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena

OCGNOcugen, Inc.

$578M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$26M

Net Income

-$26M

EPS (Diluted)

$-0.13

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$22M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$124M

Total Liabilities

$8M

Stockholders' Equity

$116M

Cash & Equivalents

$116M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$43,000	-100.0%
Gross Profit	$0	-$2M	+100.0%
Operating Income	-$26M	-$3M	-660.8%
Net Income	-$26M	-$4M	-618.1%